Andrew Taylor to Myocardium
This is a "connection" page, showing publications Andrew Taylor has written about Myocardium.
Connection Strength
8.819
-
Taylor AJ, Gutman SJ. Myocardial T1 Mapping in Heart Disease: Research Tool or New Cardiac Biomarker? JACC Cardiovasc Imaging. 2020 01; 13(1 Pt 1):55-57.
Score: 0.582
-
Costello BT, Springer F, Hare JL, Gerche A, Iles L, Ellims AH, Schmitt B, Taylor AJ. SASHA versus ShMOLLI: a comparison of T1 mapping methods in health and dilated cardiomyopathy at 3?T. Int J Cardiovasc Imaging. 2017 Oct; 33(10):1551-1560.
Score: 0.506
-
Marwick TH, Taylor AJ. Contrast-Specific Imaging Without Contrast: An Echocardiographic Technique for the Detection of Myocardial Scar. JACC Cardiovasc Imaging. 2016 11; 9(11):1252-1254.
Score: 0.485
-
Kistler PM, Taylor AJ. Myocardial Strain in the Identification of Tachycardia-Induced Cardiomyopathy: Unscrambling the Egg. JACC Cardiovasc Imaging. 2017 02; 10(2):127-129.
Score: 0.482
-
Taylor AJ, Salerno M, Dharmakumar R, Jerosch-Herold M. T1 Mapping: Basic Techniques and Clinical Applications. JACC Cardiovasc Imaging. 2016 Jan; 9(1):67-81.
Score: 0.458
-
Ngu PJ, Butler M, Pham A, Roberts SK, Taylor AJ. Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease. Int J Cardiovasc Imaging. 2016 Apr; 32(4):629-36.
Score: 0.457
-
Ellims AH, Shaw JA, Stub D, Iles LM, Hare JL, Slavin GS, Kaye DM, Taylor AJ. Diffuse myocardial fibrosis evaluated by post-contrast t1 mapping correlates with left ventricular stiffness. J Am Coll Cardiol. 2014 Mar 25; 63(11):1112-8.
Score: 0.402
-
Jaworski C, Looi JL, Martin J, Bergin P, Hare J, Kaye D, Wei A, Taylor AJ. Cardiac Imaging in FIP1L1-PDGFRA. J Am Coll Cardiol. 2013 Oct 01; 62(14):1304.
Score: 0.388
-
Iles LM, Taylor AJ. Letter by Iles and Taylor regarding article, "Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume". Circ Cardiovasc Imaging. 2013 Jul; 6(4):e25.
Score: 0.385
-
Ellims AH, Iles LM, Taylor AJ. Letter by Ellims et al regarding article, "myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy". Circ Cardiovasc Imaging. 2013 Mar 01; 6(2):e1.
Score: 0.376
-
Ling LH, Kistler PM, Ellims AH, Iles LM, Lee G, Hughes GL, Kalman JM, Kaye DM, Taylor AJ. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction. J Am Coll Cardiol. 2012 Dec 11; 60(23):2402-8.
Score: 0.368
-
Ellims AH, Iles LM, Ling LH, Hare JL, Kaye DM, Taylor AJ. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn Reson. 2012 Oct 29; 14:76.
Score: 0.368
-
Chan W, Duffy SJ, White DA, Gao XM, Du XJ, Ellims AH, Dart AM, Taylor AJ. Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion. JACC Cardiovasc Imaging. 2012 Sep; 5(9):884-93.
Score: 0.364
-
McLellan AJ, McKenzie SC, Taylor AJ. Cardiac magnetic resonance imaging predicts recovery of left ventricular function in acute onset cardiomyopathy. Heart Lung Circ. 2012 Jan; 21(1):30-5.
Score: 0.343
-
Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2011 Feb 15; 57(7):821-8.
Score: 0.327
-
Kaye DM, Iles L, Taylor AJ. Myocardial fibrosis in hypertrophic cardiomyopathy. N Engl J Med. 2010 11 11; 363(20):1971; author reply 1971.
Score: 0.321
-
Taylor AJ, Elsik M, Broughton A, Cherayath J, Leet A, Wong C, Iles L, Butler M, Pfluger H. Combined dyssynchrony and scar imaging with cardiac magnetic resonance imaging predicts clinical response and long-term prognosis following cardiac resynchronization therapy. Europace. 2010 May; 12(5):708-13.
Score: 0.306
-
Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008 Nov 04; 52(19):1574-80.
Score: 0.279
-
Taylor AJ, Bobik A, Richards M, Kaye D, Raines G, Gould P, Jennings G. Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease. Am Heart J. 2004 Aug; 148(2):e10.
Score: 0.208
-
Taylor AJ, Warren J. Diastolic Function and Fibrosis Burden: Improving Prognostication in Heart?Failure. JACC Cardiovasc Imaging. 2023 06; 16(6):797-799.
Score: 0.190
-
Fernando H, Nehme Z, Peter K, Bernard S, Stephenson M, Bray J, Cameron P, Ellims A, Taylor A, Kaye DM, Smith K, Stub D. Prehospital opioid dose and myocardial injury in patients with ST elevation myocardial infarction. Open Heart. 2020 07; 7(2).
Score: 0.156
-
Costello BT, Stub D, Hare J, Ellims AH, Wang X, Smith K, Bernard S, Nehme Z, Stephenson M, Bray JE, Cameron P, Barger B, Meredith IT, Kaye DM, Iles L, Taylor AJ. Comparison of Magnetic Resonance Analysis of Myocardial Scarring With Biomarker Release Following S-T Elevation Myocardial Infarction. Heart Lung Circ. 2019 Mar; 28(3):397-405.
Score: 0.133
-
McLELLAN AJ, Ellims AH, Prabhu S, Voskoboinik A, Iles LM, Hare JL, Kaye DM, Macciocca I, Mariani JA, Kalman JM, Taylor AJ, Kistler PM. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy. J Cardiovasc Electrophysiol. 2016 05; 27(5):571-80.
Score: 0.116
-
Nehme Z, Stub D, Bernard S, Stephenson M, Bray JE, Cameron P, Meredith IT, Barger B, Ellims AH, Taylor AJ, Kaye DM, Smith K. Effect of supplemental oxygen exposure on myocardial injury in ST-elevation myocardial infarction. Heart. 2016 Mar; 102(6):444-51.
Score: 0.115
-
Fang L, Ellims AH, Moore XL, White DA, Taylor AJ, Chin-Dusting J, Dart AM. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy. J Transl Med. 2015 Sep 24; 13:314.
Score: 0.112
-
Fang L, Beale A, Ellims AH, Moore XL, Ling LH, Taylor AJ, Chin-Dusting J, Dart AM. Associations between fibrocytes and postcontrast myocardial T1 times in hypertrophic cardiomyopathy. J Am Heart Assoc. 2013 Oct 14; 2(5):e000270.
Score: 0.098
-
Jaworski C, Looi JL, Iles LM, McLean CA, Taylor AJ, Hare JL. Bright muscle, weak heart, bad start? Heart Lung Circ. 2014 Mar; 23(3):293-4.
Score: 0.097
-
La Gerche A, Burns AT, Mooney DJ, Inder WJ, Taylor AJ, Bogaert J, Macisaac AI, Heidb?chel H, Prior DL. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J. 2012 Apr; 33(8):998-1006.
Score: 0.086
-
La Gerche A, Taylor AJ, Prior DL. Athlete's heart: the potential for multimodality imaging to address the critical remaining questions. JACC Cardiovasc Imaging. 2009 Mar; 2(3):350-63.
Score: 0.071
-
Segan L, Chieng D, Sugumar H, Voskoboinik A, Ling LH, Costello B, Azzopardi S, Nderitu Z, Parameswaran R, Amerena J, McLellan AJ, Lee G, Morton J, Joseph S, Wong M, Taylor A, Kalman JM, Kistler PM, Prabhu S. The impact of age on ablation outcomes in AF-mediated cardiomyopathy. J Cardiovasc Electrophysiol. 2023 10; 34(10):2065-2075.
Score: 0.049
-
Dagan M, Lankaputhra M, Yeung T, Tee SL, Bader I, Easton K, Linton A, McLean C, Taylor A, Bergin P, Kaye DM, Leet A, Hare JL, Patel HC. Incidence and Predictors of Eosinophilic Myocardial Hypersensitivity in Patients Receiving Home Dobutamine. J Cardiovasc Pharmacol. 2022 10 01; 80(4):623-628.
Score: 0.046
-
Stokes MB, Taylor AJ, McLean CA, D'Arcy CE, Mariani JA. Severe left ventricular hypertrophy and marked cardiac fibrosis in Danon disease. Int J Cardiol. 2016 Oct 15; 221:14-6.
Score: 0.030
-
Stub D, Smith K, Bernard S, Nehme Z, Stephenson M, Bray JE, Cameron P, Barger B, Ellims AH, Taylor AJ, Meredith IT, Kaye DM. Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction. Circulation. 2015 Jun 16; 131(24):2143-50.
Score: 0.027
-
Ling LH, Taylor AJ, Ellims AH, Iles LM, McLellan AJ, Lee G, Kumar S, Lee G, Teh A, Medi C, Kaye DM, Kalman JM, Kistler PM. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation. Heart Rhythm. 2013 Sep; 10(9):1334-9.
Score: 0.024
-
Stockton E, Hughes M, Broadhead M, Taylor A, McEwan A. A prospective audit of safety issues associated with general anesthesia for pediatric cardiac magnetic resonance imaging. Paediatr Anaesth. 2012 Nov; 22(11):1087-93.
Score: 0.023
-
Chan W, Taylor AJ, Ellims AH, Lefkovits L, Wong C, Kingwell BA, Natoli A, Croft KD, Mori T, Kaye DM, Dart AM, Duffy SJ. Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction. Circ Cardiovasc Interv. 2012 Apr; 5(2):270-8.
Score: 0.022
-
Ludman AJ, Yellon DM, Hasleton J, Ariti C, Babu GG, Boston-Griffiths E, Venugopal V, Walker M, Holdright D, Swanton H, Crake T, Brull D, Moon JC, Puranik R, Muthurangu V, Mutharangu V, Taylor A, Hausenloy DJ. Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial. Heart. 2011 Oct; 97(19):1560-5.
Score: 0.021